A FATHER-of-two from Thornbury will tackle a strenuous 220-mile cycle across rocky terrain for two sisters whose rare genetic disorder leads them to jerk uncontrollablyPhil Lucker, 36, will take on the Escape the Dragon challenge, riding from Caernarfon in Wales back to Thornbury in three days bet More …

While Huntington's disease (HD) is currently incurable, the HD research community anticipates that new disease-modifying therapies in development may slow or minimize disease progression. The success of HD research depends upon the identification of reliable and sensitive biomarkers to track "Char More …

Cell Therapeutics, Inc. reported that Germany's Federal Joint Committee (G-BA) has issued its final benefit assessment report for PIXUVRI® (pixantrone), which is indicated as a monotherapy for the treatment of adult patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have failed two or More …